NCT02751086

Brief Summary

The overall purpose is to develop and maintain a multi-institutional database comprising of information regarding surgical, clinical and oncological features of patients that will be treated for gastric cancer with robotic, laparoscopic or open approaches and subsequent follow-up. The main objective is to compare the three surgical arms on surgical and clinical outcomes, as well as on the oncological follow-up.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

April 10, 2016

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 26, 2016

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
4.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

April 22, 2019

Status Verified

April 1, 2019

Enrollment Period

3.8 years

First QC Date

April 10, 2016

Last Update Submit

April 18, 2019

Conditions

Keywords

minimally invasive surgerygastrectomyrobotic surgerylaparoscopic surgerylaparoscopyrobot-assistedroboticrobotic gastrectomylaparoscopic gastrectomyminimally invasive gastrectomy

Outcome Measures

Primary Outcomes (7)

  • Rate of patients with intraoperative adverse events

    events other than the normal course of the surgery

    During surgery

  • Mean of retrieved lymph nodes

    Count of retrieved lymph nodes at the histopathological examination of the surgical specimen

    Within 30 days after surgery

  • Rate of patients alive

    subjects alive at the planned endpoint

    1 year after surgery

  • Rate of patients alive

    subjects alive at the planned endpoint

    2 year after surgery

  • Rate of patients alive

    subjects alive at the planned endpoint

    3 year after surgery

  • Rate of patients alive

    subjects alive at the planned endpoint

    4 year after surgery

  • Rate of patients alive

    subjects alive at the planned endpoint

    5 year after surgery

Secondary Outcomes (2)

  • Mean post-operative hospital stay

    from the day after surgery to patient discharge, assessed up to 90 days

  • Rate of complications after discharge

    5 year after surgery

Study Arms (3)

Robotic Gastrectomy

Patients who will be treated for gastric cancer with the assistance of the robotic surgical system

Procedure: Robotic Gastrectomy

Laparoscopic Gastrectomy

Patients who will be treated for gastric cancer through laparoscopic devices.

Procedure: Laparoscopic Gastrectomy

Open Gastrectomy

Patients who will be treated for gastric cancer with traditional open surgery.

Interventions

Minimally invasive surgical approach, related to the availability of a robotic surgical system (eg Da Vinci surgical system), that allows a surgeon to perform surgery through a console and dedicated devices.

Robotic Gastrectomy

Minimally invasive surgical approach performed through traditional laparoscopy.

Laparoscopic Gastrectomy

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects with gastric cancer eligible for curative surgery.

You may qualify if:

  • Histologically proven gastric cancer
  • Preoperative staging work-up performed by upper endoscopy and/or endoscopic ultrasound, and CT scan and in accordance to international guidelines
  • Early Gastric Cancer
  • Advanced Gastric Cancer
  • Patients treated with curative intent in accordance to international guidelines

You may not qualify if:

  • Distant metastases: peritoneal carcinomatosis, liver metastases, distant lymph node metastases, Krukenberg tumors, involvement of other organs
  • Patients with high operative risk as defined by the American Society of Anesthesiologists (ASA) score \> 4
  • History of previous abdominal surgery for gastric cancer
  • Synchronous malignancy in other organs
  • Palliative surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Digestive Surgery, St. Mary's Hospital, University of Perugia

Terni, 05100, Italy

RECRUITING

Related Publications (10)

  • Parisi A, Nguyen NT, Reim D, Zhang S, Jiang ZW, Brower ST, Azagra JS, Facy O, Alimoglu O, Jackson PG, Tsujimoto H, Kurokawa Y, Zang L, Coburn NG, Yu PW, Zhang B, Qi F, Coratti A, Annecchiarico M, Novotny A, Goergen M, Lequeu JB, Eren T, Leblebici M, Al-Refaie W, Takiguchi S, Ma J, Zhao YL, Liu T, Desiderio J. Current status of minimally invasive surgery for gastric cancer: A literature review to highlight studies limits. Int J Surg. 2015 May;17:34-40. doi: 10.1016/j.ijsu.2015.02.021. Epub 2015 Mar 7.

    PMID: 25758348BACKGROUND
  • Parisi A, Desiderio J. Establishing a multi-institutional registry to compare the outcomes of robotic, laparoscopic, and open surgery for gastric cancer. Surgery. 2015 Apr;157(4):830-1. doi: 10.1016/j.surg.2014.12.007. Epub 2015 Jan 26. No abstract available.

    PMID: 25633739BACKGROUND
  • Desiderio J, Jiang ZW, Nguyen NT, Zhang S, Reim D, Alimoglu O, Azagra JS, Yu PW, Coburn NG, Qi F, Jackson PG, Zang L, Brower ST, Kurokawa Y, Facy O, Tsujimoto H, Coratti A, Annecchiarico M, Bazzocchi F, Avanzolini A, Gagniere J, Pezet D, Cianchi F, Badii B, Novotny A, Eren T, Leblebici M, Goergen M, Zhang B, Zhao YL, Liu T, Al-Refaie W, Ma J, Takiguchi S, Lequeu JB, Trastulli S, Parisi A. Robotic, laparoscopic and open surgery for gastric cancer compared on surgical, clinical and oncological outcomes: a multi-institutional chart review. A study protocol of the International study group on Minimally Invasive surgery for GASTRIc Cancer-IMIGASTRIC. BMJ Open. 2015 Oct 19;5(10):e008198. doi: 10.1136/bmjopen-2015-008198.

    PMID: 26482769BACKGROUND
  • Marano A, Choi YY, Hyung WJ, Kim YM, Kim J, Noh SH. Robotic versus Laparoscopic versus Open Gastrectomy: A Meta-Analysis. J Gastric Cancer. 2013 Sep;13(3):136-48. doi: 10.5230/jgc.2013.13.3.136. Epub 2013 Sep 30.

    PMID: 24156033BACKGROUND
  • Vinuela EF, Gonen M, Brennan MF, Coit DG, Strong VE. Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg. 2012 Mar;255(3):446-56. doi: 10.1097/SLA.0b013e31824682f4.

    PMID: 22330034BACKGROUND
  • Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011 Jun;14(2):113-23. doi: 10.1007/s10120-011-0042-4. No abstract available.

    PMID: 21573742BACKGROUND
  • Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011 Jun;14(2):101-12. doi: 10.1007/s10120-011-0041-5. No abstract available.

    PMID: 21573743BACKGROUND
  • Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.

    PMID: 19638912BACKGROUND
  • Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2014 May;40(5):584-591. doi: 10.1016/j.ejso.2013.09.020. No abstract available.

    PMID: 24685156BACKGROUND
  • Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010 Dec;17(12):3077-9. doi: 10.1245/s10434-010-1362-z. No abstract available.

    PMID: 20882416BACKGROUND

Related Links

MeSH Terms

Conditions

Stomach Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach Diseases

Study Officials

  • Amilcare Parisi, MD

    St. Mary's Hospital of Terni

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jacopo Desiderio, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 10, 2016

First Posted

April 26, 2016

Study Start

April 1, 2016

Primary Completion

January 1, 2020

Study Completion

December 1, 2024

Last Updated

April 22, 2019

Record last verified: 2019-04

Locations